Citation tools
"Multiple Courses of Rituximab Produce Sustained Clinical and Radiographic Efficacy and Safety in Patients with Rheumatoid Arthritis and an Inadequate Response to 1 or More Tumor Necrosis Factor Inhibitors: 5-Year Data from the REFLEX Study." The Journal of Rheumatology
39.12
(2012):
2238-2246.
Web. 19 April. 2024.